Paper6239686
Immunomodulation and therapeutic characterization of thymosin fraction five.
Talmadge JE and 3 others. Cancer Immunol Immunother, 1984. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Immunomodulation and therapeutic characterization of thymosin fraction five. Papers, record 6239686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6239686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrosarcoma | Major topic |
| Leukemia, Experimental | Major topic |
| Melanoma | Major topic |
| Neoplasms, Radiation-Induced | Major topic |
| T-Lymphocytes | Major topic |
| Thymosin | Major topic |
| Animals | |
| Cell Line | |
| Immunotherapy | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Neoplasm Metastasis | |
| Ultraviolet Rays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01-CO-23910 | NCI NIH HHS | United States | N01CO023910 | PubMed and NIH |
Source NIH RePORTER
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6707701 | Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers. | J Biol Response Mod | 1984 | https://conductscience.org/library/papers/6707701 | PubMed |
| 2 | 6232241 | The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five). | Immunopharmacology | 1984 | https://conductscience.org/library/papers/6232241 | PubMed |
| 3 | 6214350 | Thymosin modulation of regulatory T cell function. | Clin Immunol Immunopathol | 1982 | https://conductscience.org/library/papers/6214350 | PubMed |
| 4 | 216684 | The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. | J Biol Chem | 1979 | https://conductscience.org/library/papers/216684 | PubMed |
| 6 | 305674 | Thymosin treatment of children with primary immunodeficiency disease. | Transplant Proc | 1978 | https://conductscience.org/library/papers/305674 | PubMed |
| 7 | 6972536 | Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6972536 | PubMed |
| 8 | 141974 | The effect of thymosin on patients with disseminated malignancies. A phase I study. | Cancer | 1977 | https://conductscience.org/library/papers/141974 | PubMed |
| 9 | 6804089 | Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V. | Cancer Res | 1982 | https://conductscience.org/library/papers/6804089 | PubMed |
| 10 | 316979 | Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy. | Ann N Y Acad Sci | 1979 | https://conductscience.org/library/papers/316979 | PubMed |
| 11 | 6450736 | Regulation of in vitro generation of cell-mediated cytotoxicity. II. Characterization of thymosin-induced suppressor T cells. | Immunopharmacology | 1980 | https://conductscience.org/library/papers/6450736 | PubMed |
| 12 | 4551691 | Immune responses in vitro. I. Culture conditions for antibody synthesis. | Cell Immunol | 1972 | https://conductscience.org/library/papers/4551691 | PubMed |
| 13 | 7365733 | Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin. | J Reticuloendothel Soc | 1980 | https://conductscience.org/library/papers/7365733 | PubMed |
| 14 | 14130672 | ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. | J Natl Cancer Inst | 1964 | https://conductscience.org/library/papers/14130672 | PubMed |
| 15 | 679204 | Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. | Cancer Res | 1978 | https://conductscience.org/library/papers/679204 | PubMed |
| 16 | 6161188 | In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice. | J Immunol | 1981 | https://conductscience.org/library/papers/6161188 | PubMed |
| 17 | 236717 | Purification and properties of bovine thymosin. | Ann N Y Acad Sci | 1975 | https://conductscience.org/library/papers/236717 | PubMed |
| 18 | 310343 | Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/310343 | PubMed |
| 19 | 165764 | Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures. | Ann N Y Acad Sci | 1975 | https://conductscience.org/library/papers/165764 | PubMed |
| 20 | 507192 | The selection and characterization of an invasive variant of the B16 melanoma. | Am J Pathol | 1979 | https://conductscience.org/library/papers/507192 | PubMed |
| 21 | 4645593 | Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction. | Cell Immunol | 1972 | https://conductscience.org/library/papers/4645593 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27450735 | Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? | Vitam Horm | 2016 | https://conductscience.org/library/papers/27450735 | PubMed |
| 3879016 | Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers. | Springer Semin Immunopathol | 1985 | https://conductscience.org/library/papers/3879016 | PubMed |
| 3543534 | Thymosins and anti-thymosins: properties and clinical applications. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3543534 | PubMed |
| 3014672 | Thymic hormones--a clinical update. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/3014672 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6239686
GET https://conductscience.org/api/papers/v1/6239686/references?page=2